Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

September 01, 1994; Volume 270,Issue 3

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1397;
  • You have access
    Effects of lovastatin in humans on biliary lipid composition and secretion as a function of dosage and treatment interval.
    W C Duane
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 841-845;
  • You have access
    Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents.
    P J Riviere, X Pascaud, E Chevalier and J L Junien
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 846-850;
  • You have access
    Effects of KT-362, a new antiarrhythmic agent, on membrane ionic currents of guinea pig ventricular myocytes.
    Y N Cheng, T Kiyosue and M Arita
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 851-857;
  • You have access
    Effect of selenium deficiency and glutathione-modulating agents on diquat toxicity and lipid peroxidation in rats.
    J A Awad, R F Burk and L J Roberts
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 858-864;
  • You have access
    Metabolism of vesnarinone by activated neutrophils: implications for vesnarinone-induced agranulocytosis.
    J P Uetrecht, N Zahid and D Whitfield
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 865-872;
  • You have access
    Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships.
    B M Tune and C Y Hsu
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 873-880;
  • You have access
    Possible involvement of the activation of voltage-sensitive calcium channels in the ameliorating effects of nefiracetam on scopolamine-induced impairment of performance in a passive avoidance task.
    K Yamada, S Nakayama, T Shiotani, T Hasegawa and T Nabeshima
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 881-892;
  • You have access
    The endothelium of the rat renal artery plays an obligatory role in A2 adenosine receptor-mediated relaxation induced by 5'-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine.
    P L Martin and A A Potts
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 893-899;
  • You have access
    Arginine vasopressin-stimulated insulin secretion and elevation of intracellular Ca++ concentration in rat insulinoma cells: influences of a phospholipase C inhibitor 1-[6-[[17 beta-methoxyestra-1,3,5(10)-trien- 17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U-73122) and a phospholipase A2 inhibitor N-(p-amylcinnamoyl)anthranilic acid.
    T H Chen, B Lee and W H Hsu
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 900-904;
  • You have access
    Central stimulation of adrenocortical secretion by 5-hydroxytryptamine1A agonists is mediated by sympathomedullary activation.
    D Saphier and J E Welch
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 905-917;
  • You have access
    Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
    J E Welch and D Saphier
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 918-928;
  • You have access
    Role of nitric oxide-dependent and -independent mechanisms in peristalsis and accommodation in the rabbit distal colon.
    R Ciccocioppo, L Onori, E Messori, S M Candura, T Coccini and M Tonini
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 929-937;
  • You have access
    Differential functional activity of 5-hydroxytryptamine receptor ligands and beta adrenergic receptor antagonists at 5-hydroxytryptamine1B receptor sites in Chinese hamster lung fibroblasts and opossum renal epithelial cells.
    P J Pauwels and C Palmier
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 938-945;
  • You have access
    Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
    A Renouard, P S Widdowson and M J Millan
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 946-957;
  • You have access
    Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenaline.
    M J Millan, K Bervoets, J M Rivet, P Widdowson, A Renouard, S Le Marouille-Girardon and A Gobert
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 958-972;
  • You have access
    Endothelin receptors: binding and phosphoinositide breakdown in human myometrium.
    M Breuiller-Fouché, V Héluy, T Fournier and F Ferré
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 973-978;
  • You have access
    Bicarbonate-dependent amantadine transport by rat renal cortical proximal and distal tubules.
    M R Escorbar, L T Wong and D S Sitar
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 979-986;
  • You have access
    Potentiation of gamma-aminobutyric acidA receptor Cl- current correlates with in vivo anesthetic potency.
    S A Zimmerman, M V Jones and N L Harrison
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 987-991;
  • You have access
    Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
    C P France and L R Gerak
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 992-999;
  • You have access
    Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
    A Giovanni, B A Sieber, R E Heikkila and P K Sonsalla
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1000-1007;
  • You have access
    Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
    A Giovanni, P K Sonsalla and R E Heikkila
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1008-1014;
  • You have access
    Lindane increases intracellular calcium in rat myometrial smooth muscle cells through modulation of inositol 1,4,5-trisphosphate-sensitive stores.
    K A Criswell, E L Stuenkel and R Loch-Caruso
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1015-1024;
  • You have access
    Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.
    S S Negus, E R Butelman, K J Chang, B DeCosta, G Winger and J H Woods
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1025-1034;
  • You have access
    Endothelin ETB receptors couple to two distinct signaling pathways in porcine kidney epithelial LLC-PK1 cells.
    S Ozaki, M Ihara, T Saeki, T Fukami, K Ishikawa and M Yano
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1035-1040;
  • You have access
    Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine.
    P Terry, J M Witkin and J L Katz
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1041-1048;
  • You have access
    Behavioral effects of the dopamine autoreceptor agonist PD 128483 alone and in combination with cocaine.
    K E Vanover and W L Woolverton
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1049-1056;
  • You have access
    Acute ethanol inhibits calcium influxes into esophageal smooth but not striated muscle: a possible mechanism for ethanol-induced inhibition of esophageal contractility.
    A Keshavarzian, O Zorub, M Sayeed, G Urban, C Sweeney, D Winship and J Fields
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1057-1062;
  • You have access
    Telemetric blood pressure monitoring in benign 2-kidney, 1-clip renovascular hypertension: effect of chronic caffeine ingestion.
    C K Kost, P Li, C A Pfeifer and E K Jackson
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1063-1070;
  • You have access
    Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.
    J C Hartman, G M Kurc, T G Hullinger, T M Wall, R M Sheehy and R J Shebuski
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1071-1076;
  • You have access
    Selective pulmonary and venous smooth muscle relaxation by furosemide: a comparison with morphine.
    S Greenberg, C McGowan, J Xie and W R Summer
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1077-1085;
  • You have access
    Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    J E Zadina, L M Harrison, L J Ge, A J Kastin and S L Chang
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1086-1096;
  • You have access
    Dissimilar alterations of sodium-coupled uptake by platinum-coordination complexes in renal proximal tubular cells in primary culture.
    F Courjault-Gautier, D Hoet, D Leroy and H J Toutain
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1097-1104;
  • You have access
    Inhibitory effects of n-6 and n-3 hydroxy fatty acids on thromboxane (U46619)-induced smooth muscle contraction.
    J W Karanian, H Y Kim and N Salem
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1105-1109;
  • You have access
    Effects of dopamine on prolactin: interactions with cocaine self-administration by female rhesus monkeys.
    N K Mello, J H Mendelson, J M Drieze, S K Teoh, M L Kelly and J W Sholar
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1110-1120;
  • You have access
    Ethinylestradiol interacts with liver microsomes and induces binding sites for steroid hormones in the male rat liver.
    L Fernández, L D Boada, O P Luzardo, M Zumbado, J C Díaz-Chico, B N Díaz-Chico and R Chirino
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1121-1126;
  • You have access
    A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity.
    D O Freier and B A Fuchs
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1127-1133;
  • You have access
    Cocaine effects on pulsatile secretion of ACTH in men.
    S K Teoh, Z Sarnyai, J H Mendelson, N K Mello, S A Springer, J W Sholar, M Wapler, J C Kuehnle and H Gelles
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1134-1138;
  • You have access
    Serotonin inhibits gastric acid secretion through a 5-hydroxytryptamine1-like receptor in the rat.
    K J LePard and R L Stephens
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1139-1144;
  • You have access
    Molybdate depletes hepatic 3-phosphoadenosine 5-phosphosulfate and impairs the sulfation of acetaminophen in rats.
    T Oguro, Z Gregus, C Madhu, L Liu and C D Klaassen
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1145-1151;
  • You have access
    Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
    A F Hajj-Ali, T M Reilly and P C Wong
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1152-1157;
  • You have access
    Endogenous serotonin stimulates striatal dopamine release in conscious rats.
    G Yadid, K Pacak, I J Kopin and D S Goldstein
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1158-1165;
  • You have access
    Release of inflammatory mediators from guinea pig trachea by electrical field stimulation: lack of neuronal involvement.
    L B Fernandes, W C Hubbard and B J Undem
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1166-1170;
  • You have access
    Effect of protein kinase C on cyclic 3',5'-adenosine monophosphate-dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts.
    H C Lee, J J Cai and H Yu
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1171-1176;
  • You have access
    Endogenous opioids released by suspending mice by the tail selectively enhance spinal mu opioid analgesia.
    F L Smith, D A Brase, D S Dombrowski and W L Dewey
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1177-1185;
  • You have access
    Pharmakokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancer.
    F P Lacreta, J M Brennan, S L Nash, R L Comis, K D Tew and P J O'Dwyer
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1186-1191;
  • You have access
    Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    K Yin, P V Halushka, Y T Yan and P Y Wong
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1192-1196;
  • You have access
    Xanthine oxidase inhibits transmembrane signal transduction in vascular endothelial cells.
    D E Wesson and S J Elliott
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1197-1207;
  • You have access
    Inhibition of in vivo myocardial ischemic and reperfusion injury by a synthetic manganese-based superoxide dismutase mimetic.
    S C Black, C S Schasteen, R H Weiss, D P Riley, E M Driscoll and B R Lucchesi
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1208-1215;
  • You have access
    The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers.
    J E Caldwell, J Szenohradszky, V Segredo, P M Wright, C McLoughlin, M L Sharma, L D Gruenke, D M Fisher and R D Miller
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1216-1222;
  • You have access
    Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation.
    T G Kokate, B E Svensson and M A Rogawski
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1223-1229;
  • You have access
    Genetic analysis of sensitization and tolerance to cocaine.
    B K Tolliver, J K Belknap, W E Woods and J M Carney
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1230-1238;
  • You have access
    Nitric oxide as a mediator of bisacodyl and phenolphthalein laxative action: induction of nitric oxide synthase.
    T S Gaginella, N Mascolo, A A Izzo, G Autore and F Capasso
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1239-1245;
  • You have access
    Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells.
    K M Standifer, J Cheng, A I Brooks, C P Honrado, W Su, L M Visconti, J L Biedler and G W Pasternak
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1246-1255;
  • You have access
    YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    A Nishida, Y Takinami, H Yuki, A Kobayashi, S Akuzawa, T Kamato, H Ito, M Yamano, Y Nagakura and K Miyata
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1256-1261;
  • You have access
    Imidazenil, a partial positive allosteric modulator of GABAA receptors, exhibits low tolerance and dependence liabilities in the rat.
    J Auta, P Giusti, A Guidotti and E Costa
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1262-1269;
  • You have access
    Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity.
    M M Foreman, R W Fuller, K Rasmussen, D L Nelson, D O Calligaro, L Zhang, J E Barrett, R N Booher, C J Paget and M E Flaugh
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1270-1281;
  • You have access
    Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studies.
    M O'Donnell, R J Garippa, N Rinaldi, W M Selig, B Simko, L Renzetti, S A Tannu, M A Wasserman, A Welton and D R Bolin
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1282-1288;
  • You have access
    Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis.
    M O'Donnell, R J Garippa, N Rinaldi, W M Selig, J E Tocker, S A Tannu, M A Wasserman, A Welton and D R Bolin
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1289-1294;
  • You have access
    Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus.
    X P Zeng and E Burcher
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1295-1300;
  • You have access
    Spinal cholinergic alpha-2 adrenergic interactions in analgesia and hemodynamic control: role of muscarinic receptor subtypes and nitric oxide.
    A Lothe, P Li, C Tong, Y Yoon, H Bouaziz, D J Detweiler and J C Eisenach
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1301-1306;
  • You have access
    Assessment of ibuprofen-associated nephrotoxicity in renal dysfunction.
    C Y Chen, V F Pang and C S Chen
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1307-1312;
  • You have access
    Interleukin-1 beta-mediated metallothionein induction and cytoprotection against cadmium and cis-diamminedichloroplatinum.
    Y Kondo, S M Kuo and J S Lazo
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1313-1318;
  • You have access
    KN-62, a specific Ca++/calmodulin-dependent protein kinase inhibitor, reversibly depresses the rate of beating of cultured fetal mouse cardiac myocytes.
    K Okazaki, T Ishikawa, M Inui, M Tada, K Goshima, T Okamoto and H Hidaka
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1319-1324;
  • You have access
    Sera from patients with halothane hepatitis contain antibodies to halothane-induced liver antigens which are not detectable by immunoblotting.
    T L Knight, K M Scatchard, F N Van Pelt and J G Kenna
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1325-1333;
  • You have access
    delta 9-Tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages.
    W Zhu, C Newton, Y Daaka, H Friedman and T W Klein
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1334-1339;
  • You have access
    In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages.
    J L Masferrer, S T Reddy, B S Zweifel, K Seibert, P Needleman, R S Gilbert and H R Herschman
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1340-1344;
  • You have access
    Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
    C A Fornal, W J Litto, C W Metzler, F Marrosu, K Tada and B L Jacobs
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1345-1358;
  • You have access
    Effects of the putative 5-hydroxytryptamine1A antagonists BMY 7378, NAN 190 and (-)-propranolol on serotonergic dorsal raphe unit activity in behaving cats.
    C A Fornal, F Marrosu, C W Metzler, K Tada and B L Jacobs
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1359-1366;
  • You have access
    Selective suppression of rat hepatic cytochrome P450 2C11 by chloramphenicol.
    J C Kraner, E T Morgan and J R Halpert
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1367-1372;
  • You have access
    Effect of anisotonic conditions on the transport of hydrophilic model compounds across monolayers of human colonic cell lines.
    A B Noach, M Sakai, M C Blom-Roosemalen, H R de Jonge, A G de Boer and D D Breimer
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1373-1380;
  • You have access
    Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
    K Raynor, H Kong, J Hines, G Kong, J Benovic, K Yasuda, G I Bell and T Reisine
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1381-1386;
  • You have access
    Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration.
    E M Unterwald, A Ho, J M Rubenfeld and M J Kreek
    Journal of Pharmacology and Experimental Therapeutics September 1994, 270 (3) 1387-1396;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 270, Issue 3
1 Sep 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics